We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.84%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$46B
AUM Growth
-$375M
(-0.81%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
4.25%
Top 10 Holdings %
Top 10 Hldgs %
33.14%
Holding
3,504
New
954
Increased
1,038
Reduced
277
Closed
939
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$2.43B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 3 |
Amazon
AMZN
|
+$1.29B |
| 4 |
Meta Platforms (Facebook)
META
|
+$872M |
| 5 |
Eli Lilly
LLY
|
+$647M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$75.4M |
| 2 |
Tesla
TSLA
|
+$64.6M |
| 3 |
MRSH
Marsh
MRSH
|
+$38.2M |
| 4 |
Logitech
LOGI
|
+$37M |
| 5 |
Xylem
XYL
|
+$36.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.12% |
| 2 | Financials | 15.91% |
| 3 | Healthcare | 11.42% |
| 4 | Industrials | 8.98% |
| 5 | Consumer Discretionary | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Ironwood Pharmaceuticals
IRWD
$683M
| $10.8K | ﹤0.01% |
+3,079
| New | +$12.6K |
|
|
MAZE
2427
Maze Therapeutics
MAZE
$1.54B
| $10.8K | ﹤0.01% |
+361
| New | +$15.9K |
|
|
ESPR
2428
DELISTED
Esperion Therapeutics
ESPR
| $10.6K | ﹤0.01% |
3,864
+368
| +11% | +$1.17K |
|
2429
Structure Therapeutics
GPCR
$3.59B
| $10.2K | ﹤0.01% |
+212
| New | +$14.5K |
|
2430
Fulcrum Therapeutics
FULC
$288M
| $9.07K | ﹤0.01% |
+1,182
| New | +$11K |
|
2431
Rigel Pharmaceuticals
RIGL
$749M
| $9.06K | ﹤0.01% |
+335
| New | +$11.3K |
|
2432
Montauk Renewables
MNTK
$243M
| $9.03K | ﹤0.01% |
+7,852
| New | +$11.8K |
|
2433
Lyell Immunopharma
LYEL
$330M
| $8.97K | ﹤0.01% |
+447
| New | +$10.4K |
|
2434
Omeros
OMER
$916M
| $8.37K | ﹤0.01% |
+793
| New | +$9.34K |
|
|
PONY
2435
Pony AI Inc
PONY
$3.39B
| $8.37K | ﹤0.01% |
+887
| New | +$12.2K |
|
2436
Lexeo Therapeutics
LXEO
$349M
| $7.78K | ﹤0.01% |
+1,355
| New | +$9.6K |
|
2437
Keros Therapeutics
KROS
$198M
| $7.72K | ﹤0.01% |
+699
| New | +$10.8K |
|
2438
Rani Therapeutics
RANI
$87.7M
| $7.72K | ﹤0.01% |
+10,502
| New | +$13.4K |
|
|
BMNR
2439
BitMine Immersion Technologies
BMNR
$11.1B
| $7.24K | ﹤0.01% |
+366
| New | +$8.62K |
|
|
WRD
2440
WeRide Inc
WRD
$1.93B
| $7.04K | ﹤0.01% |
870
| – | – |
|
2441
SAP
SAP
$228B
| $7.02K | ﹤0.01% |
+41
| New | +$8.46K |
|
2442
Invivyd
IVVD
$178M
| $6.7K | ﹤0.01% |
+5,157
| New | +$9.47K |
|
|
OTLY
2443
Oatly Group
OTLY
$445M
| $6.04K | ﹤0.01% |
+596
| New | +$6.61K |
|
2444
Hyster-Yale Materials Handling
HY
$725M
| $5.27K | ﹤0.01% |
162
-174
| -52% | -$5.97K |
|
|
UPB
2445
Upstream Bio Inc
UPB
$367M
| $4.29K | ﹤0.01% |
+477
| New | +$8.58K |
|
2446
iShares MSCI Brazil ETF
EWZ
$9.14B
| $4.04K | ﹤0.01% |
110
-14,909
| -99% | -$545K |
|
2447
iShares MSCI Mexico ETF
EWW
$1.97B
| $3.85K | ﹤0.01% |
53
-7,221
| -99% | -$546K |
|
2448
Mercer International
MERC
$45.3M
| $3.62K | ﹤0.01% |
2,549
| – | – |
|
2449
Sprott Uranium Miners ETF
URNM
$1.91B
| $3.6K | ﹤0.01% |
61
-76
| -55% | -$5.19K |
|
2450
PepGen
PEPG
$137M
| $3.55K | ﹤0.01% |
+2,006
| New | +$11.3K |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q1 2026 Portfolio in Review
As of Q1 2026, Zurich Cantonal Bank held 3,504 positions worth $46B, down 0.81% from $46.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Zurich Cantonal Bank deployed $1.95B of net new capital in Q1 2026, opening 954 new positions and adding to 1,038 existing holdings. Its largest new stake was UBS Group: 56,674,567 shares worth $2.17B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Bank of America, an estimated $75.4M trimmed.
- Zurich Cantonal Bank's largest Q1 2026 buy was UBS Group: 56,674,567 shares worth $2.17B.
- Zurich Cantonal Bank added most to Microsoft in Q1 2026, an estimated $221M increase.
- Zurich Cantonal Bank's biggest Q1 2026 reduction was Bank of America, cutting an estimated $75.4M.
- Zurich Cantonal Bank fully exited CyberArk in Q1 2026, selling an estimated $12.7M.
- Zurich Cantonal Bank's ten largest holdings make up 33% of its $46B portfolio in Q1 2026.
- Zurich Cantonal Bank opened 954 new positions and closed 939 in Q1 2026.
- Zurich Cantonal Bank's portfolio value fell 0.81% quarter-over-quarter to $46B.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.